Director, Payer Strategy, Marketing and Policy jobs in United States
cer-icon
Apply on Employer Site
company-logo

Dyne Therapeutics · 9 hours ago

Director, Payer Strategy, Marketing and Policy

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. The Director of Payer Marketing, Strategy and Policy will develop and implement access strategies for product launches, ensuring efficient outreach to healthcare providers, patients, and payers while navigating state and federal policies that impact access.

BiotechnologyHealth CareMedicalPharmaceutical
check
Growth Opportunities

Responsibilities

Support development of Payer Value Propositions and associated resources. Craft compelling, evidence-based value propositions tailored to payers (commercial, Medicare, Medicaid). Align messaging with product clinical, economic, and humanistic value
Create Access Marketing Tools & Resources. Develop payer-facing materials such unmet need, PIE decks, value decks and objection handlers while informing AMCP dossier and HEOR material development. Ensure materials are compliant with regulatory and legal standards
Market Access Strategy Development. Collaborate with cross-functional teams (e.g., HEOR, Pricing, Medical Affairs, Sales) to build payer strategy across product lifecycle
Support Pricing & Contracting Strategy. Provide US payer perspective to guide contract pull-through strategies
Payer & Stakeholder Engagement. Support Account Directors and Field Access teams with payer engagement initiatives
Develop customized tools and communication strategies for key stakeholders (e.g., payers, IDNs, ACOs)
Partner with Patient Support, Marketing, Commercial Analytics and Sales to continually monitor, assess and evolve the distribution strategy and tactics to ensure objectives are met and exceeded
Develop HCP and patient-facing resources in support of Patient Support Services and Distribution, inclusive of services across Hub, Financial Assistance, and accessing product
Training & Enablement. Train Market Access and Sales teams on payer messaging, tools, and tactics. Create and maintain access marketing training content
Develop and execute on a strategic plan for state level policy engagement to overcome any patient access hurdles that may impact patient's ability to access product in FFS Medicaid. Work with outside partners to stay abreast of state issues and programs that impact patient access

Qualification

Market Access StrategyPayer Marketing ExperienceBio/Pharmaceutical ExperienceRare Disease ExperienceFederalState Policy KnowledgePatient Support ServicesInfluential PersonalityCollaboration SkillsCommunication SkillsProblem-Solving Skills

Required

BA/BS degree required; advanced degree (MBA, PhD, PharmD) preferred
10+ years of bio/pharmaceutical experience required with a key understanding of current US pharmaceutical payer, patient support, and distribution processes
Demonstrated access marketing experience in process development for coordination with Payers, HUB, co-pay, distribution, and other patient service providers
Influential personality with the ability to simplify and clarify complex issues to broad and diverse audiences
Experience and understanding of federal and state policy, coverage, coding and reimbursement for buy and bill products and infused therapies
Enterprise mindset that makes culture and values come to life in everyday activities
Experience in a small, rapidly growing biotech with the ability to operate and maneuver in a start-up environment while keeping a solutions-oriented mentality
Demonstrates an authentic willingness and capability to roll up sleeves rather than relying on others for delivery
Ability to travel to meet business objectives

Preferred

advanced degree (MBA, PhD, PharmD)
Previous rare disease experience and Buy-and-Bill models, including infusion products

Company

Dyne Therapeutics

twittertwittertwitter
company-logo
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Funding

Current Stage
Public Company
Total Funding
$1.67B
Key Investors
Hercules CapitalAtlas Venture
2025-12-09Post Ipo Equity· $402.5M
2025-06-30Post Ipo Equity· $230M
2025-06-30Post Ipo Debt· $100M

Leadership Team

leader-logo
John Cox
Chief Executive Officer
linkedin
Company data provided by crunchbase